John S. Bomalaski

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers

Brian J. Dillon, Víctor G. Prieto, Steven A. Curley et al. · Cancer · 2004 · 337 citations

Medicine, Cancer Biology, Oncology +17

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Mark Ensor, Frederick W. Holtsberg, John S. Bomalaski et al. · PubMed · 2002 · 319 citations

Life Sciences, Biochemistry, Oncology +15

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo et al. · Annals of Oncology · 2018 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies

Paolo A. Ascierto, Stefania Scala, Giuseppe Castello et al. · Journal of Clinical Oncology · 2005 · 249 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +16

Pegylated Arginine Deiminase Treatment of Patients With Unresectable Hepatocellular Carcinoma: Results From Phase I/II Studies

Francesco Izzo, Paolo Marra, Gerardo Beneduce et al. · Journal of Clinical Oncology · 2004 · 249 citations

Medicine, Oncology, Pharmacology +17